Century Therapeutics Inc (IPSC) — Cash Flow Reinvestment Rate
Century Therapeutics Inc (IPSC) has a Cash Flow Reinvestment Rate of 0.51x as of March 2022, reinvesting $44.04 Million (capex $4.07 Million plus investments $-39.97 Million) from operating cash flow of $86.75 Million. Check earnings quality score of Century Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Century Therapeutics Inc Cash Flow Reinvestment Rate (2015–2022)
Historical reinvestment intensity for Century Therapeutics Inc across 2 annual periods. Explore Century Therapeutics Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Century Therapeutics Inc (2015–2022)
Year-by-year capital reinvestment analysis for Century Therapeutics Inc. For live market cap and broader valuation context, see Century Therapeutics Inc (IPSC) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 3.42x | $48.08 Million | $14.05 Million | $30.60 Million | ▲ +1114.0% |
| 2015 | 0.28x | $29.39 Million | $104.30 Million | $29.39 Million | — |